作者: Uday N. Kumar , Teresa Marco , Leslie A. Saxon
DOI: 10.1385/1-59259-842-0:123
关键词: Heart failure 、 Implantable cardioverter-defibrillator 、 Intensive care medicine 、 Economic cost 、 Population 、 Disease 、 Medicine 、 Newly diagnosed 、 Coronary sinus 、 Cardiac resynchronization therapy
摘要: Heart failure is a disease of immense burden and cost to individuals society. It estimated that more than 4.5 million people in the United States currently suffer from heart failure, 400,000 cases are newly diagnosed each year (1). The prevalence increases with age such nearly 10% population will be affected ninth decade life (2). Furthermore, leading cause hospitalizations older 65 years, it was there would 1 for 2004, an economic exceeding $40 billion (3). Given tremendous scope great deal research has gone into finding therapies can reduce its morbidity mortality.